Biliary excretion of taurolithocholate-sulfate and Temocaprilat (cas 110221-53-9) in cholestatic rats induced by bile duct-ligation and ethinylestradiol
-
Add time:08/08/2019 Source:sciencedirect.com
Down-regulation of multidrug resistance protein 2 (Mrp2), a major canalicular organic anion transporter, has been reported in various cholestatic models and in patients with cholestasis. In the present study, biliary excretion of taurolithocholate-sulfate and Temocaprilat (cas 110221-53-9), substrates of Mrp2, was studied in bile duct-ligated rats and in cholestatic rats induced by ethinylestradiol (EE). Biliary excretion of temocaprilat was more markedly decreased in bile duct-ligated rats than that of taurolithocholate-sulfate. In contrast, biliary excretion of both compounds were similarly inhibited in EE-treated rat. Such difference of the degree of inhibition may have been caused by the different degree of the inhibition of unknown canalicular transporters other than Mrp2 in bile duct-ligated rats.
We also recommend Trading Suppliers and Manufacturers of Temocaprilat (cas 110221-53-9). Pls Click Website Link as below: cas 110221-53-9 suppliers
Prev:The effects of temocapril, a new angiotensin converting enzyme inhibitor, on the quality of life in hypertensive patients
Next:Activation of various subtypes of G-protein α subunits by partial agonists of the adenosine A1 receptor) - 【Back】【Close 】【Print】【Add to favorite 】